Phase 3
topic on 2 shows · 3 statements across 2 episodes
3 statements about Phase 3, every show
Phase 3 clinical trials account for 29% of drug R&D spending
“29% of all R&D for a drug is spent right here. So phase one is nine percent, phase two is 12%, phase three is 29%.”
Only 8% of drugs entering clinical development pass Phase 3
“So of the 69% that even make it into clinical development, you've got 36% left at graduating phase one, then 13% left graduating phase two, then all the way at the end, eight percent graduating out of phase three.”